GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GTBP | AZN | AMGN | GILD | GSK |
| Company | GT Biopharma Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.3810 | 202.55 | 346.18 | 138.26 | 58.96 |
| High | 0.3900 | 204.73 | 351.72 | 141.40 | 59.57 |
| Low | 0.3730 | 202.07 | 345.41 | 137.60 | 58.14 |
| Latest | 0.3832 | 204.38 | 350.95 | 140.45 | 59.18 |
| Change | -0.0058 | +2.14 | +1.13 | +1.42 | +0.24 |
| % Change | -1.49% | +1.06% | +0.32% | +1.02% | +0.41% |
| Volume | 280,767 | 2,205,592 | 2,106,291 | 6,407,672 | 3,753,344 |
| 20-Day Average Volume | 621,848 | 1,898,766 | 2,795,935 | 6,076,943 | 4,260,427 |
| Previous Close | 0.3890 | 202.24 | 349.82 | 139.03 | 58.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4244 | 195.00 | 350.31 | 139.28 | 55.17 |
| 20-Day Raw Stochastic | 22.59% | 88.28% | 47.12% | 51.17% | 95.20% |
| 20-Day Relative Strength | 39.57 | 58.93 | 47.13 | 49.38 | 63.50 |
| Weighted Alpha | -86.29 | +50.63 | +25.73 | +33.84 | +67.18 |
| Today's Opinion | 100% Sell | 88% Buy | 56% Buy | 56% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 40% Buy | 40% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 56% Buy | 88% Buy | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.28% since 04/07/26 | +1.78% since 04/07/26 | +3.22% since 04/07/26 | +1.19% since 04/07/26 | +5.99% since 04/07/26 |
| Low | 0.3506 on 04/13/26 | 200.70 on 04/13/26 | 342.35 on 04/08/26 | 137.02 on 04/13/26 | 56.51 on 04/08/26 |
| High | 0.4268 on 04/08/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 59.57 on 04/14/26 |
| 1-Month | |||||
| %Chg | -7.55% since 03/13/26 | +7.63% since 03/13/26 | -4.17% since 03/13/26 | -3.13% since 03/13/26 | +10.85% since 03/13/26 |
| Low | 0.3506 on 04/13/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 51.54 on 03/20/26 |
| High | 0.4949 on 03/24/26 | 207.30 on 04/10/26 | 370.89 on 03/16/26 | 146.71 on 03/17/26 | 59.57 on 04/14/26 |
| 3-Month | |||||
| %Chg | -41.94% since 01/14/26 | +6.07% since 01/14/26 | +6.68% since 01/14/26 | +13.20% since 01/14/26 | +16.53% since 01/14/26 |
| Low | 0.3506 on 04/13/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 47.62 on 01/20/26 |
| High | 0.7799 on 01/16/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | -46.78% since 10/14/25 | +20.05% since 10/14/25 | +19.43% since 10/14/25 | +18.54% since 10/14/25 | +34.05% since 10/14/25 |
| Low | 0.3506 on 04/13/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.85 on 10/24/25 |
| High | 1.1500 on 11/14/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,275 | 313,655,648 | 188,792,608 | 172,567,104 | 119,735,248 |
| Shares Outstanding, K | 31,554 | 1,550,908 | 539,685 | 1,241,222 | 2,031,477 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -28,350,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,424,970,000 |
| Last Quarter Net Income | -23,030,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 851,670,000 |
| 60-Month Beta | 1.19 | 0.35 | 0.47 | 0.39 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 03/02/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.68 on 02/04/26 |
| Latest Earnings Date | 05/21/26 | 05/05/26 | 04/30/26 | 04/23/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.470 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.27 | 16.07 | 17.05 | 12.88 |